Common Contracts
2 similar Underwriting Agreement contracts by HCA Healthcare, Inc.
HCA INC. $1,000,000,000 5.450% Senior Notes due 2031 $1,300,000,000 5.600% Senior Notes due 2034 $1,500,000,000 6.000% Senior Notes due 2054 $700,000,000 6.100% Senior Notes due 2064 UNDERWRITING AGREEMENTUnderwriting Agreement • February 21st, 2024 • HCA Healthcare, Inc. • Services-general medical & surgical hospitals, nec • New York
HCA Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several parties named in Schedule I hereto (each an “Underwriter” and together, the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the respective amounts set forth in such Schedule I of (i) $1,000,000,000 aggregate principal amount of its 5.450% Senior Notes due 2031 (the “2031 Notes” and, together with the 2031 Guarantee (as defined below), the “2031 Securities”), (ii) $1,300,000,000 aggregate principal amount of its 5.600% Senior Notes due 2034 (the “2034 Notes” and, together with the 2034 Guarantee (as defined below), the “2034 Securities”), (iii) $1,500,000,000 aggregate principal amount of its 6.000% Senior Notes due 2054 (the “2054 Notes” and, together with the 2054 Guarantee (as defined below), the “2054 Securities”) and (iv) $700,000,000 aggregate principal amount of its 6.100% Senior Notes due 2064 (the “2064 Notes” and, together with the 2064 Guarantee (as
HCA INC. $1,000,000,000 5.200% Senior Notes due 2028 $1,250,000,000 5.500% Senior Notes due 2033 $1,000,000,000 5.900% Senior Notes due 2053 UNDERWRITING AGREEMENTUnderwriting Agreement • May 2nd, 2023 • HCA Healthcare, Inc. • Services-general medical & surgical hospitals, nec • New York
HCA Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several parties named in Schedule I hereto (each an “Underwriter” and together, the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the respective amounts set forth in such Schedule I of (i) $1,000,000,000 aggregate principal amount of its 5.200% Senior Notes due 2028 (the “2028 Notes” and, together with the 2028 Guarantee (as defined below), the “2028 Securities”), (ii) $1,250,000,000 aggregate principal amount of its 5.500% Senior Notes due 2033 (the “2033 Notes” and, together with the 2033 Guarantee (as defined below), the “2033 Securities”) and (iii) $1,000,000,000 aggregate principal amount of its 5.900% Senior Notes due 2053 (the “2053 Notes,” and, together with the 2053 Guarantee (as defined below), the “2053 Securities”). The 2028 Notes, the 2033 Notes and the 2053 Notes are collectively referred to hereafter as the “Notes” and the 2028 Securities, the 2033 S
